Cost-utility and budget impact analysis for stopping the inappropriate use of proton pump inhibitors after cessation of NSAID or low-dose acetylsalicylic acid treatment

In accordance with current guidelines, proton pump inhibitors (PPIs) are now generally prescribed as a protective co-medication in patients taking non-steroidal anti-inflammatory drugs (NSAIDs) or low-dose acetylsalicylic acid (LDASA). However, less attention is paid to the corresponding discontinua...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Chau, Sek Hung (VerfasserIn) , Sluiter, Reinier Luuk (VerfasserIn) , Hugtenburg, Jacqueline Geertruida (VerfasserIn) , Wensing, Michel (VerfasserIn) , Kievit, Wietske (VerfasserIn) , Teichert, Martina (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2020
In: Drugs & aging
Year: 2019, Jahrgang: 37, Heft: 1, Pages: 67-74
ISSN:1179-1969
DOI:10.1007/s40266-019-00713-5
Online-Zugang:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1007/s40266-019-00713-5
Volltext
Verfasserangaben:Sek Hung Chau, Reinier Luuk Sluiter, Jacqueline Geertruida Hugtenburg, Michel Wensing, Wietske Kievit, Martina Teichert

MARC

LEADER 00000caa a2200000 c 4500
001 1693736829
003 DE-627
005 20230427031657.0
007 cr uuu---uuuuu
008 200401r20202019xx |||||o 00| ||eng c
024 7 |a 10.1007/s40266-019-00713-5  |2 doi 
035 |a (DE-627)1693736829 
035 |a (DE-599)KXP1693736829 
035 |a (OCoLC)1341313121 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Chau, Sek Hung  |e VerfasserIn  |0 (DE-588)1161476520  |0 (DE-627)1024769402  |0 (DE-576)506559238  |4 aut 
245 1 0 |a Cost-utility and budget impact analysis for stopping the inappropriate use of proton pump inhibitors after cessation of NSAID or low-dose acetylsalicylic acid treatment  |c Sek Hung Chau, Reinier Luuk Sluiter, Jacqueline Geertruida Hugtenburg, Michel Wensing, Wietske Kievit, Martina Teichert 
264 1 |c 2020 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Published online: 27 September 2019 
500 |a Gesehen am 01.04.2020 
520 |a In accordance with current guidelines, proton pump inhibitors (PPIs) are now generally prescribed as a protective co-medication in patients taking non-steroidal anti-inflammatory drugs (NSAIDs) or low-dose acetylsalicylic acid (LDASA). However, less attention is paid to the corresponding discontinuation of a PPI after cessation of NSAID or LDASA treatment. 
534 |c 2019 
700 1 |a Sluiter, Reinier Luuk  |e VerfasserIn  |4 aut 
700 1 |a Hugtenburg, Jacqueline Geertruida  |e VerfasserIn  |4 aut 
700 1 |a Wensing, Michel  |d 1967-  |e VerfasserIn  |0 (DE-588)173088341  |0 (DE-627)698011937  |0 (DE-576)13394042X  |4 aut 
700 1 |a Kievit, Wietske  |e VerfasserIn  |4 aut 
700 1 |a Teichert, Martina  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Drugs & aging  |d Berlin [u.a.] : Springer, 1991  |g 37(2020), 1, Seite 67-74  |h Online-Ressource  |w (DE-627)327644281  |w (DE-600)2043689-0  |w (DE-576)273880810  |x 1179-1969  |7 nnas  |a Cost-utility and budget impact analysis for stopping the inappropriate use of proton pump inhibitors after cessation of NSAID or low-dose acetylsalicylic acid treatment 
773 1 8 |g volume:37  |g year:2020  |g number:1  |g pages:67-74  |g extent:8  |a Cost-utility and budget impact analysis for stopping the inappropriate use of proton pump inhibitors after cessation of NSAID or low-dose acetylsalicylic acid treatment 
856 4 0 |u https://doi.org/10.1007/s40266-019-00713-5  |x Resolving-System  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20200401 
993 |a Article 
994 |a 2020 
998 |g 173088341  |a Wensing, Michel  |m 173088341:Wensing, Michel  |d 910000  |d 910100  |e 910000PW173088341  |e 910100PW173088341  |k 0/910000/  |k 1/910000/910100/  |p 4 
999 |a KXP-PPN1693736829  |e 3617287514 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"display":"Chau, Sek Hung","role":"aut","given":"Sek Hung","family":"Chau"},{"role":"aut","given":"Reinier Luuk","display":"Sluiter, Reinier Luuk","family":"Sluiter"},{"family":"Hugtenburg","display":"Hugtenburg, Jacqueline Geertruida","given":"Jacqueline Geertruida","role":"aut"},{"family":"Wensing","display":"Wensing, Michel","given":"Michel","role":"aut"},{"family":"Kievit","given":"Wietske","role":"aut","display":"Kievit, Wietske"},{"family":"Teichert","display":"Teichert, Martina","given":"Martina","role":"aut"}],"name":{"displayForm":["Sek Hung Chau, Reinier Luuk Sluiter, Jacqueline Geertruida Hugtenburg, Michel Wensing, Wietske Kievit, Martina Teichert"]},"id":{"eki":["1693736829"],"doi":["10.1007/s40266-019-00713-5"]},"physDesc":[{"extent":"8 S."}],"note":["Published online: 27 September 2019","Gesehen am 01.04.2020"],"relHost":[{"title":[{"subtitle":"evaluations of age-related changes in drug disposition and drug therapy in the elderly","title":"Drugs & aging","title_sort":"Drugs & aging"}],"part":{"volume":"37","text":"37(2020), 1, Seite 67-74","year":"2020","issue":"1","extent":"8","pages":"67-74"},"language":["eng"],"pubHistory":["1.1991 -"],"recId":"327644281","origin":[{"dateIssuedKey":"1991","publisher":"Springer ; Adis Intern.","dateIssuedDisp":"1991-","publisherPlace":"Berlin [u.a.] ; Auckland [u.a.]"}],"titleAlt":[{"title":"Drugs and aging"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"physDesc":[{"extent":"Online-Ressource"}],"disp":"Cost-utility and budget impact analysis for stopping the inappropriate use of proton pump inhibitors after cessation of NSAID or low-dose acetylsalicylic acid treatmentDrugs & aging","id":{"zdb":["2043689-0"],"issn":["1179-1969"],"eki":["327644281"]},"note":["Gesehen am 23.04.14"]}],"recId":"1693736829","origin":[{"dateIssuedDisp":"2020","dateIssuedKey":"2020"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title_sort":"Cost-utility and budget impact analysis for stopping the inappropriate use of proton pump inhibitors after cessation of NSAID or low-dose acetylsalicylic acid treatment","title":"Cost-utility and budget impact analysis for stopping the inappropriate use of proton pump inhibitors after cessation of NSAID or low-dose acetylsalicylic acid treatment"}],"language":["eng"]} 
SRT |a CHAUSEKHUNCOSTUTILIT2020